Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360º synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Technological advancements in empty capsules
3.2.1.2 Growing prevalence of chronic ailments such as cardiovascular diseases worldwide
3.2.1.3 Increasing intake of dietary supplements and vitamins
3.2.2 Industry pitfalls & challenges
3.2.2.1 Fluctuating raw material prices
3.2.2.2 Cultural practices and dietary restrictions
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive positioning matrix
4.4 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Million)
5.1 Key trends
5.2 Gelatin based capsules
5.2.1 Hard capsules
5.2.2 Soft capsules
5.3 Vegetarian capsules
Chapter 6 Market Estimates and Forecast, By Source, 2018 – 2032 ($ Million)
6.1 Key trends
6.2 Porcine gelatin
6.3 Bovine derived gelatin
6.4 Bone meal
6.5 Hydroxy propyl methyl cellulose (HPMC)
6.6 Starch materials & pullulan
Chapter 7 Market Estimates and Forecast, By Functionality, 2018 – 2032 ($ Million)
7.1 Key trends
7.2 Immediate release
7.3 Sustained release
7.4 Delayed release
Chapter 8 Market Estimates and Forecast, By Capsule Type, 2018 – 2032 ($ Million)
8.1 Key trends
8.2 Size "000"
8.3 Size "00"
8.4 Size "0"
8.5 Size "1"
8.6 Size "2"
8.7 Size "3"
8.8 Size "4"
8.9 Size "5"
Chapter 9 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Million)
9.1 Key trends
9.2 Antibiotic and antibacterial drugs
9.3 Vitamins and dietary supplements
9.4 Antacid and antiflatulent preparations
9.5 Cardiovascular therapy drugs
9.6 Other therapeutic applications
Chapter 10 Market Estimates and Forecast, By End-User, 2018 – 2032 ($ Million)
10.1 Key trends
10.2 Pharmaceuticals industry
10.3 Nutraceuticals industry
10.4 Cosmetics industry
10.5 Research laboratories
Chapter 11 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Million)
11.1 Key trends, by region
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 ACG
12.2 Bright Pharma Caps Inc.
12.3 CapsCanada Corporation
12.4 Erawat Pharma Limited
12.5 HealthCaps India
12.6 Lonza Group
12.7 Medi-Caps Ltd.
12.8 Mitsubishi Chemical Holdings Corporation
12.9 Nectar Lifesciences Ltd.
12.10 Qingdao Yiqing Biotechnology Co., Ltd.
12.11 Seoheung Co., Ltd.
